1) Reason for revision of the ASR vs other total conventional hips
| Revision diagnosis | ASR number | ASR %revision | ASR % of all primary procedures | Other conventional hips (number) | Other conventional hip revisions (% revision) | Other conventional hips (% primary) |
| Loosening/lysis | 92 | 43.8% | 2.1% | 1427 | 29.3% | .9% |
| Prosthesis dislocation | 15 | 7.1% | .3% | 1385 | 28.5% | .8% |
| infection | 42 | 20% | 1% | 804 | 16.5% | .5% |
| fracture | 19 | 9% | .4% | 725 | 14.9% | .4% |
| pain | 7 | 3.3% | .2% | 97 | 2% | .1% |
| Other (14 categories) | 35 | 16% | .9% | 429 | 1% | 0 |
| revisions | 210 | 100% | 4.8% | 4867 | 100% | 2.9% |
| Primary | 4406 | | | 16,698 | | |
[ comments from connie: When you look at these numbers, you begin to see why a surgeon would have used this Depuy ASR device. This chart shows several likely reasons:
- Prosthesis dislocation is 400% higher in the Other hips vs Depuy ASR
- Fracture is 60% higher in the other hips vs the Depuy ASR
- loosening of the prosthesis and lysis is about 70% higher in the Depuy ASR (Lysis (Greek λύσις, lýsis from lýein "to separate") refers to the breaking down of a cell, often by viral, enzymic, or osmotic mechanisms that compromise its integrity)
This little exercise reaffirms the concept that with every reward in medicine there are risks. Somehow, surgeons have to balance them out sometimes absent complete information.]
2. Number of revisions of ARS by year of implant (remember the data here is all from Australia joint registry.) Note: Primary procedures performed in later years have had less follow up time therefore the number revised is expected to be less than the number revised in early years which is why you wouldn't calculate percents.
In the early years, you can see that the percents are relatively high comparatively:
- 4.7% /2004
- 7%/ 2005
| Year of Implant | Number revised | Total Number |
| 2004 | 4 | 84 |
| 2005 | 41 | 583 |
| 2006 | 60 | 958 |
| 2007 | 56 | 2284 |
| 2008 | 45 | 1172 |
| 2009 | 4 | 425 |
| total | 210 | 4406 |
this is kind of interesting as well because if you look at the calculation of these rates in the last few posts, something seems to be incongruous...not sure what? Likely the cumulative numbers would be better to look at not the annual numbers. These were published in the last few posts.
Anyway, this was very interesting especially the first point above. It provides perspective on the surgeon's dilemma doesn't it?
where is Smith and Nephew getting their statis from, McMinns original controlled patient group of 2385?? If they are how tainted is this information seeing it is coming from a single source, and McMinn, the partial inventor of the BHR also had a financial interest in this device once it was approved to be marketed in the USA
ReplyDelete